Yuichi Hiyama

The impact of interferon‐free direct‐acting antivirals on clinical outcome after curative treatment for hepatitis C virus–associated hepatocellular carcinoma: Comparison with interferon‐based therapy

Yuko Nagaoki, Michio Imamura, Yuno Nishida et al. · Journal of Medical Virology · 2018 · 36 citations

Pharmacy, Oncology, Pharmacology +17

Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts

Daisuke Shimizu, Ryo Yuge, Yuki Kitadai et al. · International Journal of Molecular Sciences · 2024 · 23 citations · Full text

Medicine, Immunology, Oncology +17

The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis

Rina Otani, Hidehiko Takigawa, Ryo Yuge et al. · Cancers · 2023 · 16 citations · Full text

Medicine, Oncology, Pharmacology +11

Diagnostic Yield of Colon Capsule Endoscopy in Detection of Superficial Colorectal Lesions

Ichiro Otani, Shiro Oka, Shinji Tanaka et al. · Digestion · 2019 · 15 citations

Medicine, Clinical Sciences, Pathology +17

Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: A pilot study

Yumiko Tatsukawa, Masataka Tsuge, Yoshiiku Kawakami et al. · Antiviral Therapy · 2017 · 14 citations

Pharmacy, Pharmacology, Pharmacotherapy +17